Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group.

Shepard RC, Levy DE, Berlin JD, Stuart K, Harris JE, Aviles V, Thomas JP, Benson AB
Oncology. 2004 66 (4): 303-9

PMID: 15218298 · DOI:10.1159/000078331

MeSH Terms (20)

Adult Aged Antimetabolites, Antineoplastic Antineoplastic Agents, Phytogenic Antineoplastic Combined Chemotherapy Protocols Carcinoma Deoxycytidine Disease-Free Survival Docetaxel Drug Administration Schedule Female Humans Infusions, Intravenous Male Middle Aged Pancreatic Neoplasms Survival Analysis Taxoids Treatment Failure United States

Connections (1)

This publication is referenced by other Labnodes entities: